Table 4.
Percentage of models in which a variable was statistically significant; percentage of models in which a variable had a positive coefficient sign; the percentage of models in which a variable had a negative coefficient sign for the covariates present in the joint models fitted for data sets A, B, C, and D; and the average of those percentages across all data sets.
| Variable | Data set (%) | Average (%) | ||||||||||||||||||
| A | B | C | D |
|
||||||||||||||||
| ssa | posb | negc | ss | pos | neg | ss | pos | neg | ss | pos | neg | ss | pos | neg | ||||||
| Male (ref: female) | N/Ad | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 | 46 | 54 | 0 | 46 | 54 | |||||
| Year of disease onset | N/A | N/A | N/A | N/A | N/A | N/A | 92 | 75 | 25 | N/A | N/A | N/A | 92 | 75 | 25 | |||||
| Year biologic therapy initiation | 82 | 36 | 64 | 83 | 67 | 25 | N/A | N/A | N/A | N/A | N/A | N/A | 83 | 52 | 45 | |||||
| Age at start of the first biologic therapy | 82 | 0 | 100 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 82 | 0 | 100 | |||||
| Disease years until start of the first biologic therapy | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 15 | 0 | 100 | 15 | 0 | 100 | |||||
| HLA-B27e | N/A | N/A | N/A | N/A | N/A | N/A | 83 | 0 | 100 | N/A | N/A | N/A | 83 | 0 | 100 | |||||
| Years of education | 82 | 100 | 0 | 100 | 100 | 0 | N/A | N/A | N/A | 85 | 100 | 0 | 91 | 100 | 0 | |||||
| Baseline CRPf | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 44 | 100 | 0 | 44 | 100 | 0 | |||||
| Baseline BASFIg | 50 | 100 | 0 | 75 | 100 | 0 | 25 | 63 | 37 | 50 | 100 | 0 | 50 | 91 | 9 | |||||
| CRP | 67 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 92 | 100 | 0 | |||||
| ESRh | 50 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 88 | 100 | 0 | |||||
| BASDAIi | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | |||||
| BASFI | 33 | 33 | 66 | 50 | 50 | 50 | 50 | 50 | 50 | 60 | 60 | 40 | 48 | 48 | 52 | |||||
| ASDASj | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | |||||
ass: percentage of models in which variable is statistically significant.
bpos: percentage of models in which variable has positive coefficient.
cneg: percentage of models in which variable has negative coefficient.
dN/A: not applicable.
eHLA-B27: human leukocyte antigen B27.
fCRP: C-reactive protein.
gBASFI: Bath Ankylosing Spondylitis Functional Index.
hESR: erythrocyte sedimentation rate.
iBASDAI: Bath Ankylosing Spondylitis Disease Activity Index.
jASDAS: Ankylosing Spondylitis Disease Activity Score.